Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.3) was added to the study history, replacing the previous revision (v3.6.2) and updating the record's documentation.
    Difference
    0.1%
    Check dated 2026-07-04T03:50:07.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The history shows a new revision tag v3.6.2 was added and v3.6.0 removed, representing an administrative update to the record rather than substantive changes to the trial.
    Difference
    0.1%
    Check dated 2026-06-26T23:31:52.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Recruitment status updated to No longer looking for participants. The history also shows a new Revision: v3.6.0 and the removal of the previous Revision: v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-12T15:34:02.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Version bumped in the site footer from v3.5.4 to v3.5.5, signaling a new deployment of the ClinicalTrials.gov interface. No user-facing content changes are indicated by this update.
    Difference
    0.1%
    Check dated 2026-06-05T10:23:14.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a new build/version of the page's history metadata.
    Difference
    0.1%
    Check dated 2026-05-14T23:23:03.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The latest revision entry in the record history has been updated to v3.5.3, replacing the prior v3.5.2. This indicates the study record was updated to version v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-30T18:18:04.000Z thumbnail image

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.